Core Scientific Is Maintained at Buy by B. Riley Securities

What happened

B. Riley Securities kept a Buy rating on Core Scientific but cut its price target to $31.00 per share from $42.00, according to ratings actions reported by Benzinga. The change lowers the brokerage's expected share value while keeping its positive recommendation.

Confirmed

Global impact / market context

A lower price target means the analyst expects less upside than before, which can make some investors reduce position sizes or wait for clearer signs. Because the Buy rating stays, the signal is caution about expected value rather than a full change of view.

Analyst inference

Price target changes are common after analysts revise assumptions about future revenue, costs or risk, but this report gives no reason for the cut. Investors comparing Core Scientific with peers may treat the lower target as a sign of softer expectations across the company's business.

Analyst inference

What to watch

1. Whether B. Riley Securities issues further research explaining why the Core Scientific price target moved to $31.00 from $42.00, since the supplied text gives no stated reason. Confirmed
2. Watch whether other analysts follow with their own rating or price target changes for Core Scientific, which would show whether views on the company are shifting more broadly. Proposed
3. Track Core Scientific's future updates on capital spending, cash available and revenue, because weaker expectations for these items can justify lower price targets over time. Analyst inference

Evidence

• Original source link unavailable